Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer

被引：0
|
作者：
Rosell, Rafael [1 ,2 ]
Aguilar-Hernandez, Andres [2 ]
Gonzalez-Cao, Maria [2 ]
机构：
[1] Germans Trias & Pujol Res Inst, Badalona 08916, Spain
[2] Hosp Quiron Dexeus, IOR, Barcelona 08028, Spain
来源：
CANCERS | 2023年 / 15卷 / 09期
关键词：
KINASE;
D O I：
10.3390/cancers15092519
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
    Bircan, Sema
    Baloglu, Huseyin
    Kucukodaci, Zafer
    Bircan, Ahmet
    MEDICAL ONCOLOGY, 2014, 31 (08)
  • [32] EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
    Sema Bircan
    Huseyin Baloglu
    Zafer Kucukodaci
    Ahmet Bircan
    Medical Oncology, 2014, 31
  • [33] Cytological samples for the study of EGFR, KRAS and ALK mutations in non-small cell lung cancer
    Becker, Caroline
    Carcereny Costa, Enric
    Andreo Garcia, Felipe
    Castella, Eva
    Lletjos Sanuy, Mariona
    Moran, Teresa
    Mijangos Basterra, Erika
    Sanz Santos, Jose
    Centeno Clemente, Carmen
    Ruiz Manzano, Juan
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [34] Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer
    Yu, Jian
    Kane, Susan
    Wu, Jiong
    Benedettini, Elisa
    Li, Daiqiang
    Reeves, Cynthia
    Innocenti, Gregory
    Wetzel, Randy
    Crosby, Katherine
    Becker, Alison
    Ferrante, Michelle
    Cheung, Wan Cheung
    Hong, Xiqiang
    Chirieac, Lucian R.
    Sholl, Lynette M.
    Haack, Herbert
    Smith, Bradley L.
    Polakiewicz, Roberto D.
    Tan, Yi
    Gu, Ting-Lei
    Loda, Massimo
    Zhou, Xinmin
    Comb, Michael J.
    CLINICAL CANCER RESEARCH, 2009, 15 (09) : 3023 - 3028
  • [35] Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer
    Xia, Junbo
    Luo, Man
    Dai, Lujun
    Wang, Liusheng
    Wang, Limin
    Zhu, Jing
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (05)
  • [36] EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
    Wenfeng Fang
    Yihua Huang
    Shaodong Hong
    Zhonghan Zhang
    Minghui Wang
    Jiadi Gan
    Wenjing Wang
    Honglin Guo
    Kai Wang
    Li Zhang
    BMC Cancer, 19
  • [37] Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis
    Paz-Ares, Luis
    Soulieres, Denis
    Melezinek, Ivan
    Moecks, Joachim
    Keil, Lorenz
    Mok, Tony
    Rosell, Rafael
    Klughammer, Barbara
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (1-2) : 51 - 69
  • [38] Effect of EGFR mutations on gefitinib in advanced previous treated non-small-cell lung cancer
    Guo, J.
    Zhou, C.
    Deng, Q.
    Ren, S.
    Zhang, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] TKI as First Line Treatment in Advanced Non-Small-Cell Lung Cancer with EGFR Mutations
    Guerreiro, Ines
    Silva, Ana Vitor
    Rodrigues, Ana
    Oliveira, Cristina
    Pousa, Ines
    Oliveira, Julio
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1244 - S1245
  • [40] Potential Usage of Afanitib in the Treatment of Non-Small-Cell Lung Cancer with Uncommon EGFR Mutations
    Harada, Taishi
    Yamaba, Yukiko
    Hayata, Hiroki
    Okuda, Takashi
    Kimura, Yoshishige
    Komaki, Toshiyuki
    Kagawa, Keizo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1241 - S1241
12345